myNEO Therapeutics aims this year to double the team in size due to our growing project portfolio with multiple different partners. The neoantigen discovery team has been joined by Gitta Boons and Lies van Olmen earlier this year and we are currently recruiting at...
CureVac (Nasdaq: CVAC) and myNEO Therapeutics will partner to identify novel targets for mRNA-based cancer vaccine development. We’re convinced that combining our tumor characterization and neoantigen discovery methods with an mRNA vaccination technology holds great...
Abera Bioscience, a listed Swedish company with vaccine platforms for prophylactic and therapeutic vaccines today signed an agreement with Belgian company myNEO Therapeutics for collaboration within the neoantigen discovery field. The companies will work closely...
Opgeven Is Geen Optie (OIGO) is organizing an info session on March 24th where Lien Lybaert will explain in understandable language to cancer patients, their loved ones & sympathizers what has fascinated her for 10 years now: IMMUNOTHERAPY. What is the role of the...
myNEO fully endorses a work hard/play hard balance and so we have at least once a month an afterwork drink or dinner. We think it is important to keep the team spirit alive to enable better interpersonal communication leading to more efficient team working...
